Treatment of Danhong Injection Combined with Naoxintong Capsule in Acute Coronary Syndrome Patients Undergoing PCI Operation: Study for a Randomized Controlled and Double-Blind Trial

Table 1

Demographic and basic clinical characteristics of treatment and control group.

	Treatment	Control
Initial subjects,	65	65
Age, year	68.88 ± 5.75	67.26 ± 5.49
Gender, , male/female	50/40	53/37
Systolic pressure, mmHg	148.79 ± 13.01	147.74 ± 11.83
Diastolic pressure, mmHg	77.76 ± 6.76	76.79 ± 6.55
Body mass index, kg/m^2	23.20 ± 1.63	23.05 ± 1.65
Risk factor, (%)
Smoking history	41 (45.6)	38 (42.2)
Drinking history	35 (38.9)	32 (35.6)
Hypertension	60 (66.7)	62 (68.9)
Hyperlipidemia	36 (40.0)	41 (45.6)
Diabetes mellitus	23 (25.6)	22 (24.4)
Cardiac function 1/2/3/4,	8/49/33/0	11/46/33/0

eported as mean ± standard deviation, unless noted otherwise.